RxDoctor Payments Data

Randall Provost

Internal Medicine · Sylva, NCNPI 1003873456

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,841 and has fallen 98.9% since, to $21 in 2022.

$2,910in general payments, 2019–2025

Across 207 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$359
  • AstraZeneca$333
  • Boehringer Ingelheim$242
  • Novo Nordisk$240
  • GSK$217
  • Takeda Pharmaceuticals U.S.A., Inc.$212
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$2,904100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,910 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina →

Other internal medicine in Sylva

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →